doi: 10.3389/fphar.2025.1586231 Received 21 March 2025 Accepted 30 April 2025 Published 09 June 2025 Volume 16 - 2025 Edited by Irwin Rose Alencar de Menezes, Regional University of Cariri, Brazil Reviewed by Alaaeldin Ahmed Hamza, National Organization for Drug Control and Research (NODCAR), Egypt Mohannad A
Because semaglutide injections are designed for people with type 2 diabetes or for weight management, they come with several benefits
[PubMed] [Frontiers] [PubMed] Setin-Suero E, Surez-Pinilla M, Surez-Pinilla P, Crespo-Facorro B, Ayesa-Arriola R
Regular follow-ups are integral to tailoring the GLP-1 therapy to meet individual patient needs, adjusting dosages, and monitoring progress
Fasting before injection does not accelerate semaglutide absorption or enhance its appetite-suppressing effect
What is semaglutide and why is everyone talking about GLP-1 medications